Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.00
0.00 (0.00%)
Apr 29, 2026, 10:18 AM EDT - Market open
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,554,496
Market Cap
2.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| Adial Pharmaceuticals | 5 |
BBLG News
- 3 months ago - Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook - GlobeNewsWire
- 4 months ago - Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months - GlobeNewsWire
- 8 months ago - Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook - Business Wire
- 8 months ago - Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference - Business Wire
- 10 months ago - Bone Biologics Announces Closing of $5.0 Million Public Offering - Business Wire
- 10 months ago - Why Is Bone Biologics Stock Surging On Friday? - Benzinga
- 10 months ago - Bone Biologics Announces Pricing of $5.0 Million Public Offering - Business Wire
- 10 months ago - Bone Biologics Files Patent Application for Bone Regeneration Technology - Business Wire